tirzepatide versus semaglutide once weekly vs Tirzepatide: Which GLP-1 Wins for Weight Loss? Tirzepatide vs Semaglutide: Weight Loss,

doi: 10.22038/ijbms.2020.39815.9436 170 RodaGChien NgSKotzePGArgolloMPanaccioneRSpinelliAet al

GLP-1 receptor agonists augment insulin secretion after the meal and inhibit glucagon production from pancreatic alpha cells at hyper- or euglycemia

M.MoralesA.BlascoC.ColellA.MariM.Garcia-RuizC.et al (2005)

Ertugliflozin The Evaluation of Ertugliflozin Efficacy and Safety Cardiovascular Outcomes Trial (VERTIS CV) was a multicentre RCT in which 8246 patients with T2D and atherosclerotic cardiovascular disease were randomized to receive either 5 mg or 15 mg of ERTU versus placebo once a day

Managing Ozempic's Effects: What to Expect and When to Seek Help Successfully managing Ozempic therapy requires understanding what to expect during treatment and recognising when professional medical input is needed